Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia November 2023 23(11):e393-e404 - Subject
- Language
- ISSN
- 2152-2650